Keyphrases
Prostate Cancer
73%
P2Y1
64%
P2Y Receptors
63%
Prostate Cancer Cells
57%
P2Y1R
37%
Abiraterone Acetate
31%
Purinergic Receptors
24%
DU145
22%
Prostate Radiotherapy
20%
RNA Therapeutics
20%
Preclinical Validation
20%
Machine Learning
20%
Anti-prostate Cancer
20%
Cancer Apoptosis
20%
Cancer Genes
20%
Cancer Cell Death
20%
Androgen Receptor Antagonist
20%
Gene Data
20%
Gingivobuccal Cancers
20%
Learnheuristics
20%
Anticancer Agents
20%
Synthetic Agonists
20%
Cell Death Induction
20%
Cell Growth
20%
Molecular Interactions
20%
Functional Characterization
20%
Ligand-receptor Binding
20%
Stabilizer
20%
Indoline
16%
Cell Death
15%
Methyl
15%
Cell Proliferation
15%
P-hydroxyphenyl
13%
Nitrophenyl
13%
Small Interfering RNA (siRNA)
12%
Molecular Mechanism
12%
Apoptosis
11%
Receptor Agonist
10%
Carbonitrile
10%
Oral Cancer
10%
Induced Apoptosis
9%
IC50
9%
RNA-based
8%
Cell-to-cell
8%
G Protein-coupled Receptor
8%
PC-3 Cells
7%
Cell Cycle Arrest
7%
Cancer Invasion
7%
DNA Damage
7%
Adherence Properties
7%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Purinergic P2Y1 Receptor
76%
Small Interfering RNA
31%
Malignant Neoplasm
27%
Abiraterone Acetate
25%
Protein P53
23%
Combination Therapy
21%
Carcinogen
20%
Rare Disease
20%
Androgen Receptor
20%
Immunotherapy
20%
Untranslated RNA
20%
Anticarcinogen
20%
Diseases
20%
Mouth Cancer
15%
Receptor Agonist
10%
G Protein Coupled Receptor
7%
Cyanide
7%
Cancer Growth
7%
IC50
7%
Receptor
6%
Purinergic Receptor
5%
Cancer Prognosis
5%
Carcinoma
5%
Synapsin II
5%
